K. A. van Nifterik

Genetic profiling of a distant second glioblastoma multiforme after radiotherapy: Recurrence or second primary tumor?

W. Vandertop, S. Leenstra, P. Sminia, 2006, Journal of neurosurgery.

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

S. Leenstra, P. Sminia, L. Stalpers, 2010, British Journal of Cancer.

Anti-tumour effects by a trimodal combination of temozolomide, meloxicam and X-rays in cultures of human glioma cells

B. Slotman, K. A. van Nifterik, J. van den Berg, 2011, International journal of radiation biology.

Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.

S. Leenstra, P. Sminia, L. Stalpers, 2007, International journal of radiation oncology, biology, physics.